These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 22406355)
1. Is there a path beyond BOLD? Molecular imaging of brain function. Koretsky AP Neuroimage; 2012 Aug; 62(2):1208-15. PubMed ID: 22406355 [TBL] [Abstract][Full Text] [Related]
2. Using manganese-enhanced MRI to understand BOLD. Silva AC Neuroimage; 2012 Aug; 62(2):1009-13. PubMed ID: 22245640 [TBL] [Abstract][Full Text] [Related]
4. The future of acquisition speed, coverage, sensitivity, and resolution. Wald LL Neuroimage; 2012 Aug; 62(2):1221-9. PubMed ID: 22421052 [TBL] [Abstract][Full Text] [Related]
5. Finding the BOLD effect in brain images. Ogawa S Neuroimage; 2012 Aug; 62(2):608-9. PubMed ID: 22309802 [TBL] [Abstract][Full Text] [Related]
6. The future of functional MRI in clinical medicine. Bullmore E Neuroimage; 2012 Aug; 62(2):1267-71. PubMed ID: 22261374 [TBL] [Abstract][Full Text] [Related]
7. The history and role of long duration stimulation in fMRI. Krueger G; Granziera C Neuroimage; 2012 Aug; 62(2):1051-5. PubMed ID: 22281678 [TBL] [Abstract][Full Text] [Related]
8. The NIH experience in first advancing fMRI. Turner R Neuroimage; 2012 Aug; 62(2):632-6. PubMed ID: 21855641 [TBL] [Abstract][Full Text] [Related]
9. The future of susceptibility contrast for assessment of anatomy and function. Reichenbach JR Neuroimage; 2012 Aug; 62(2):1311-5. PubMed ID: 22245644 [TBL] [Abstract][Full Text] [Related]
10. fMRI at 20: has it changed the world? Rosen BR; Savoy RL Neuroimage; 2012 Aug; 62(2):1316-24. PubMed ID: 22433659 [TBL] [Abstract][Full Text] [Related]
11. A short history of causal modeling of fMRI data. Stephan KE; Roebroeck A Neuroimage; 2012 Aug; 62(2):856-63. PubMed ID: 22248576 [TBL] [Abstract][Full Text] [Related]
12. Future trends in Neuroimaging: Neural processes as expressed within real-life contexts. Hasson U; Honey CJ Neuroimage; 2012 Aug; 62(2):1272-8. PubMed ID: 22348879 [TBL] [Abstract][Full Text] [Related]
13. The characterization of dynamic susceptibility effects. Weisskoff RM Neuroimage; 2012 Aug; 62(2):1014-6. PubMed ID: 22245353 [TBL] [Abstract][Full Text] [Related]
14. The Yale experience in first advancing fMRI. Blamire AM Neuroimage; 2012 Aug; 62(2):637-40. PubMed ID: 22032943 [TBL] [Abstract][Full Text] [Related]
15. The intravascular susceptibility effect and the underlying physiology of fMRI. Villringer A Neuroimage; 2012 Aug; 62(2):995-9. PubMed ID: 22305989 [TBL] [Abstract][Full Text] [Related]
16. The role of susceptibility weighted imaging in functional MRI. Haacke EM; Ye Y Neuroimage; 2012 Aug; 62(2):923-9. PubMed ID: 22245649 [TBL] [Abstract][Full Text] [Related]
17. Which "neural activity" do you mean? fMRI, MEG, oscillations and neurotransmitters. Singh KD Neuroimage; 2012 Aug; 62(2):1121-30. PubMed ID: 22248578 [TBL] [Abstract][Full Text] [Related]
18. The emergence of doing "nothing" as a viable paradigm design. Lowe MJ Neuroimage; 2012 Aug; 62(2):1146-51. PubMed ID: 22245648 [TBL] [Abstract][Full Text] [Related]
19. The BOLD post-stimulus undershoot, one of the most debated issues in fMRI. van Zijl PC; Hua J; Lu H Neuroimage; 2012 Aug; 62(2):1092-102. PubMed ID: 22248572 [TBL] [Abstract][Full Text] [Related]
20. Early development of arterial spin labeling to measure regional brain blood flow by MRI. Koretsky AP Neuroimage; 2012 Aug; 62(2):602-7. PubMed ID: 22245338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]